Award
Delivery Order #SPE2DP26F7787
Delivery Order for Guaifenesin under Definitive Pharmaceutical Supply Contract
Buyer
Defense Logistics Agency
Award Amount
$11.08
Ceiling
$11.08
Awarded
July 20, 2026
Period of Performance
Jul 20, 2026 – Aug 04, 2026
Identifier
SPE2DP26F7787
NAICS
424210
This is a delivery order contract awarded to DMS Pharmaceutical Group Inc., a pharmaceutical distributor known for supplying a wide range of critical drug inventories to federal health agencies. The order pertains to the procurement of Guaifenesin, a medication used primarily to relieve chest congestion. This award is part of a larger definitive contract intended to ensure a reliable and continuous supply of essential pharmaceuticals, which is vital for supporting public health initiatives. The scope includes the timely delivery of the specified drug within a short performance window, reflecting operational responsiveness in pharmaceutical supply chains. The contract falls under a competitive award process as part of an indefinite delivery vehicle (IDV) framework, ensuring strategic and efficient procurement. The delivery order is scheduled for performance over a brief, defined period in mid-2026, complementing the broader long-term supply agreement that began in 2025 and extends through 2038.
Description
8512250209!GUAIFENESIN EXTENDE